PLMO-02 - Plenary session – Innovative drug discovery and access

Auditorium

Chair(s)

Prof. Ross Mckinnon, Chairman of the FIP Board of Pharmaceutical Sciences, Australia and Dr Rebecka Isaksson, FIP Scientific Secretary, UK

Introduction

This plenary session on innovative drug discovery and access will address current challenges, integrating industry-driven innovation with patient-centric clinical trials. A panel discussion titled, “Pharmacy’s role in bridging the gap,” will discuss new clinical trial models, innovative drug discoveries post-COVID-19 pandemic, and the role of pharmacists in improving access to groundbreaking medicines. It will showcase successful collaborations and recent breakthroughs in drug discovery.

Programme

16:30 – 16:45

Integration of research and innovation into policy and practice through the paradigm of a learning health system
Dr Timothy Hanlon, Group Manager Research, Evaluation and Innovation, Ministry of Health, New Zealand
16:45 – 17:00 Title to be confirmed
Prof. Marc Blockman, Professor in the Department of Internal Medicine at UCT/GSH and Chair of the Pharmacovigilance Committee of the South African Health Products Regulatory Authority (SAHPRA), South Africa
17:00 – 17:15

Title to be confirmed
Dr Boitumelo Semete-Makototlela, CEO South African Health Products Regulatory Authority (SAHPRA), South Africa
17:15 – 17:30

Alignment of drug discovery and development strategies with unmet medical need – are we there yet?
Prof. Sarel Malan, School of Pharmacy, University of Western Cape Town, South Africa